William P. Burke's most recent trade in Axogen Inc. was a trade of 19,227 Common Stock done at an average price of $8.1 . Disclosure was reported to the exchange on Nov. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.14 per share. | 10 Nov 2025 | 19,227 | 19,327 (0%) | 0% | 8.1 | 156,508 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 19,227 | 3,591 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 24.01 per share. | 10 Nov 2025 | 19,227 | 100 (0%) | 0% | 24.0 | 461,640 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 3,591 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 10 Nov 2025 | 3,591 | 100 (0%) | 0% | 24.0 | 86,249 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.14 per share. | 10 Nov 2025 | 3,591 | 3,691 (0%) | 0% | 8.1 | 29,231 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 24.05 per share. | 05 Nov 2025 | 11,431 | 100 (0%) | 0% | 24.0 | 274,893 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.14 per share. | 05 Nov 2025 | 11,431 | 11,531 (0%) | 0% | 8.1 | 93,048 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 11,431 | 28,165 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 24.01 per share. | 05 Nov 2025 | 5,347 | 100 (0%) | 0% | 24.0 | 128,371 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.14 per share. | 05 Nov 2025 | 5,347 | 5,447 (0%) | 0% | 8.1 | 43,525 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 5,347 | 22,818 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 29 Oct 2025 | 20,436 | 20,536 (0%) | 0% | 6.3 | 128,747 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 20,436 | 0 | - | - | Stock Option (right to buy) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 19.15 per share. | 29 Oct 2025 | 20,436 | 100 (0%) | 0% | 19.2 | 391,435 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 19,799 | 39,596 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 29 Oct 2025 | 19,799 | 100 (0%) | 0% | 22 | 435,578 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.14 per share. | 29 Oct 2025 | 19,799 | 19,899 (0%) | 0% | 8.1 | 161,164 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 18,248 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 29 Oct 2025 | 18,248 | 100 (0%) | 0% | 23 | 419,704 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. | 29 Oct 2025 | 18,248 | 18,348 (0%) | 0% | 7.0 | 128,466 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.02 per share. | 22 Oct 2025 | 1,457 | 100 (0%) | 0% | 18.0 | 26,252 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 06 Oct 2025 | 736 | 1,557 (0%) | 0% | 18.0 | 13,249 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 02 Oct 2025 | 14,571 | 2,293 (0%) | 0% | 18.2 | 265,283 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 02 Oct 2025 | 7,620 | 16,864 (0%) | 0% | 18.0 | 137,200 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 02 Oct 2025 | 7,600 | 0 (0%) | 0% | 18.2 | 138,367 | Common Stock |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 02 Oct 2025 | 2,400 | 7,600 (0%) | 0% | 18.0 | 43,224 | Common Stock |
| Axogen Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 14,150 | 14,150 | - | - | Restricted Stock Units | |
| Axogen Inc | William P. Burke | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 09 Jun 2025 | 4,073 | 24,484 (0%) | 0% | 10.6 | 43,215 | Common Stock |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 28,557 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 16,653 (0%) | 0% | - | Common Stock | |
| Axogen Inc | William P. Burke | Director | Purchase of securities on an exchange or from another person at price $ 6.56 per share. | 23 Aug 2023 | 10,000 | 10,000 (0%) | 0% | 6.6 | 65,600 | Common Stock |
| Axogen Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 6.31 per share. | 23 Aug 2023 | 6,000 | 6,000 (0%) | 0% | 6.3 | 37,860 | Common Stock |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 357 | 66,447 (0%) | 0% | 35.3 | 12,595 | Ordinary Shares |
| Miromatrix Medical Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,201 | 134,356 | - | 0 | Common Stock | |
| Miromatrix Medical Inc | William P. Burke | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 80,155 | - | 1.6 | 50,000 | Common Stock |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 593 | 66,090 (0%) | 0% | 76.2 | 45,163 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 02 Mar 2023 | 281 | 66,683 (0%) | 0% | 75.3 | 21,153 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,168 | 20,168 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,125 | 67,719 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.36 per share. | 28 Feb 2023 | 755 | 66,964 (0%) | 0% | 76.4 | 57,654 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 62.31 per share. | 06 Jan 2023 | 108 | 55,594 (0%) | 0% | 62.3 | 6,729 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 79.04 per share. | 02 Sep 2022 | 718 | 55,486 (0%) | 0% | 79.0 | 56,749 | Ordinary Shares |
| Miromatrix Medical Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 12,788 | 48,905 | - | 0 | Common Stock | |
| Axogen Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2022 | 59,395 | 0 | - | - | Stock Option (right to purchase) | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 59.08 per share. | 05 Jul 2022 | 213 | 56,204 (0%) | 0% | 59.1 | 12,583 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 08 Mar 2022 | 1,037 | 55,991 (0%) | 0% | 70.1 | 72,694 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,038 | 13,038 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,445 | 58,395 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 4,361 | 4,361 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 1,026 | 57,028 (0%) | 0% | 70.4 | 72,238 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 341 | 58,054 (0%) | 0% | 74.5 | 25,404 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 63.81 per share. | 06 Jan 2022 | 80 | 50,950 (0%) | 0% | 63.8 | 5,105 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 17,452 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 03 Jan 2022 | 17,452 | 43,669 (0%) | 0% | 11.5 | 200,000 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 03 Jan 2022 | 9,750 | 50,786 (0%) | 0% | 7.2 | 69,713 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 9,750 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.96 per share. | 03 Jan 2022 | 2,633 | 41,036 (0%) | 0% | 76.0 | 200,003 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.60 per share. | 03 Jan 2022 | 1,402 | 51,269 (0%) | 0% | 21.6 | 30,283 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 1,402 | 6,098 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.09 per share. | 03 Jan 2022 | 919 | 49,867 (0%) | 0% | 76.1 | 69,924 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.03 per share. | 03 Jan 2022 | 399 | 50,870 (0%) | 0% | 76.0 | 30,336 | Ordinary Shares |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.51 per share. | 23 Aug 2021 | 22,667 | 30,291 (0%) | 0% | 60.5 | 1,371,580 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 11,435 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.64 per share. | 23 Aug 2021 | 11,435 | 52,958 (0%) | 0% | 41.6 | 476,153 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.21 per share. | 23 Aug 2021 | 11,232 | 41,523 (0%) | 0% | 34.2 | 384,247 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 11,232 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 66.60 per share. | 01 Jul 2021 | 4,293 | 30,291 (0%) | 0% | 66.6 | 285,914 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.87 per share. | 14 Jun 2021 | 190 | 34,584 (0%) | 0% | 59.9 | 11,375 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 07 Jun 2021 | 411 | 34,774 (0%) | 0% | 55.1 | 22,642 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 17,933 | 17,933 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 17,677 | 35,423 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,628 | 17,746 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 18 May 2021 | 238 | 35,185 (0%) | 0% | 55.2 | 13,135 | Common Stock |
| Haemonetics Corp | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 17 May 2021 | 219 | 11,118 (0%) | 0% | 56.0 | 12,257 | Common Stock |